Potential preventive role of low-dose methotrexate against incident recorded psychosis: a retrospective cohort study based on electronic health records

Fabiana Corsi-Zuelli, Maxime Taquet, Bill Deakin, Rachel Upthegrove · 2026

Read Potential preventive role of low-dose methotrexate against incident recorded psychosis: a retrospective cohort study based on electronic health records by Fabiana Corsi-Zuelli, Maxime Taquet, Bill Deakin, Rachel Upthegrove (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427570.txt.

Description

Fabiana Corsi-Zuelli and colleagues ask, in a 2026 records study, whether a common arthritis drug might lower the chance of later psychosis. Methotrexate, taken in low weekly doses for rheumatoid arthritis, calms the immune system. Some earlier work hinted it might also protect the mind. The team used a large United States health records network covering care since the year 2000.

They compared adults aged 45 or younger who started methotrexate with patients who started one of 14 other arthritis drugs. Over five years, new recorded psychosis was less common after methotrexate than after two common pain drugs, naproxen and diclofenac. No clear edge appeared against biologic drugs. Records can mislead, so the authors treat this as a lead for trials, not proof.

Catalog record

CREATORFabiana Corsi-Zuelli, Maxime Taquet, Bill Deakin, Rachel Upthegrove
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE85271
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13427570

Browse the full library · About the Tower of Babel